The United States Patent and Trademark Office (PTO) recently finalized its patent utility guidelines. Promulgated by the PTO, the new guidelines will be used by patent examiners in determining whether a claimed invention should be awarded patent protection ;and will be used by patent applicants and attorneys who file patent applications. The guidelines focus primarily on the utility standards for gene and gene fragment patents, an issue that was featured in the PTO\u27s 1999 Revised Interim Utility Guidelines and has been the subject of considerable public debate
The debate over human gene patents was recently reignited by New York federal Judge Robert Sweet, wh...
Since the mapping of the human genome and the technical innovations in the field of biotechnology, p...
The past two decades have been a period of rapid evolution in the science of biotechnology and there...
This Comment examines the newly revised PTO utility examination guidelines for biotechnology patents...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
As public and private sector initiatives raced to complete the sequence of the human genome, patent ...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
The recent decision by Judge Sweet in Association for Molecular Pathology, et al. v. U.S. Patent and...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
At issue is whether or not isolated DNA is patent eligible under the U.S. Patent Law and the implica...
Patents on human genetic information have been controversial among different groups for different re...
There is significant domestic and international opposition to gene patents based on the fact that ge...
With new technologies, concerns about gene patent claims regarding isolated DNA are becoming less re...
This Article introduces the scientific background necessary to understand the practice of gene seque...
The debate over human gene patents was recently reignited by New York federal Judge Robert Sweet, wh...
Since the mapping of the human genome and the technical innovations in the field of biotechnology, p...
The past two decades have been a period of rapid evolution in the science of biotechnology and there...
This Comment examines the newly revised PTO utility examination guidelines for biotechnology patents...
A revolution in genetics has been occurring since Watson and Crick discovered the structure of the d...
As public and private sector initiatives raced to complete the sequence of the human genome, patent ...
The emergence of genetic medicine following decades of molecular biology research has been accompa...
The recent decision by Judge Sweet in Association for Molecular Pathology, et al. v. U.S. Patent and...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
In 2005, an article in the highly influential journal Science reported that roughly 20% of human gen...
At issue is whether or not isolated DNA is patent eligible under the U.S. Patent Law and the implica...
Patents on human genetic information have been controversial among different groups for different re...
There is significant domestic and international opposition to gene patents based on the fact that ge...
With new technologies, concerns about gene patent claims regarding isolated DNA are becoming less re...
This Article introduces the scientific background necessary to understand the practice of gene seque...
The debate over human gene patents was recently reignited by New York federal Judge Robert Sweet, wh...
Since the mapping of the human genome and the technical innovations in the field of biotechnology, p...
The past two decades have been a period of rapid evolution in the science of biotechnology and there...